Freiburg, Germany: November 13, 2024 - StageBio, a leading provider of GLP-compliant histology, pathology, image analysis and archiving services for both preclinical and clinical research, is excited to announce their European division will be relocating.
Mt. Jackson, VA – October 1, 2024: StageBio Senior Director of Medical Device & Neuropathy Sarah Cramer, DVM, PhD, DACVP, will co-present a Continuing Education course at the American College of Toxicology (ACT) 45th Annual Meeting in Austin, Texas.
Established by the merger of industry leaders, StageBio is an integrated partner serving the full spectrum of your histopathology needs. Our experienced team of laboratory staff, board-certified pathologists and archiving specialists are both experts in their respective fields and stewards of your projects’ success.
StageBio expands its capabilities on both sides of the Atlantic with the acquisition of TPL Path Labs.